Filing Details
- Accession Number:
- 0001171843-16-013102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-09 19:05:37
- Reporting Period:
- 2016-11-07
- Filing Date:
- 2016-11-09
- Accepted Time:
- 2016-11-09 19:05:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
898437 | Anika Therapeutics Inc. | ANIK | Surgical & Medical Instruments & Apparatus (3841) | 043145961 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227947 | I Joseph Bower | 32 Wiggins Avenue Bedford MA 01730 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-11-07 | 1,540 | $12.36 | 38,513 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-11-07 | 431 | $44.26 | 38,082 | No | 4 | F | Direct | |
Common Stock | Disposition | 2016-11-09 | 500 | $43.40 | 37,582 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-11-09 | 40 | $43.31 | 37,542 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Right | Disposition | 2016-11-07 | 1,540 | $0.00 | 1,540 | $12.36 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct |
Footnotes
- Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016.
- Reflects 431 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 7, 2016.
- Reflects an aggregate of 540 shares of common stock sold to satisfy tax obligations related to the exercise of the above listed SARs award by the Reporting Person on November 9, 2016.